Crossmark

Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-019-3989-9

Published Online: 2020-01-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Shen https://orcid.org/0000-0002-4097-557X
Li, Jin-pu
Funding

Funding for this research was provided by:

Beijing Municipal Science & Technology Commission (Z181100001718123)

special research projects of national traditional Chinese medicine clinical research demonstration base of Guang’anmen Hospital (2017S379)
License Information

Text and Data Mining valid from 2020-01-06

Version of Record valid from 2020-01-06
More Information

Article History

Received: 22 August 2019

Accepted: 11 December 2019

First Online: 6 January 2020

Ethics approval and consent to participate

: This study has been approved by the Ethics Committee of Guang’anmen Hospital (approval number 2018–055-KY-01). Patients who agree to participate and sign the informed consent will be involved.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below